Gastrointestinal Cancer News

A novel evaluation of biomarkers known to be associated with pancreatic cancer significantly improved detection of early-stage disease compared with previous tests, according to results of a double-blind phase 2 trial.

Cancer diagnoses fell significantly below expectations in 2020 due to the COVID-19 pandemic but recovered to projected levels the following year, according to results of a cross-sectional study.

PHILADELPHIA— AI-assisted-colonoscopy significantly increased the number of colonoscopy procedures in which only benign lesions were removed without additional adenomatous polyps, according to data at the ACG Annual Scientific Meeting.

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

The delivery of transvascular energy reduced pain and improved quality of life within 7 days among patients with pancreatic cancer, according to a topline data announcement.

PHILADELPHIA—An AI-assisted endoscopy module minorly improved adenoma detection during colonoscopy, but “had no impact” on serrated polyp detection in patients with positive stool tests, a presenter said at the ACG Annual Scientific Meeting.

BOSTON — Fewer patients hospitalized for acute pulmonary embolism with pancreatic cancer died in 2020 compared with rates in 2001, according to a presentation at the CHEST Annual Meeting.

PHILADELPHIA — Patients with a false-positive Shield test result did not appear to be at increased risk for non-colorectal cancer malignancies at 1 year compared with those with a true-negative result, according to a presenter here.

Lack of health insurance contributes to a high percentage of racial and ethnic disparities in advanced-stage diagnoses for several cancer types, according to results of a mediation analysis.